Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JD

John E. Donello — 140 Patents

AbbVie: 135 patents #4 of 1,308Top 1%
ESExonhit Therapeutics, Sa: 12 patents #2 of 30Top 7%
TIThe Salk Institute: 3 patents #1 of 32Top 4%
SSSalk Institute For Biological Studies: 1 patents #291 of 521Top 60%
Dana Point, CA: #3 of 393 inventorsTop 1%
California: #1,156 of 386,348 inventorsTop 1%
Overall (All Time): #7,197 of 4,157,543Top 1%
140 Patents All Time
John E. Donello has been granted 140 US patents while listed as an inventor at AbbVie. The first was granted in 2000 and the most recent in May 2022. John E. Donello ranks #7,197 of 4,157,543 US inventors in our database (top 0.17%). Patent records list John E. Donello in Dana Point, CA, US.

Issued Patents All Time

Showing 1–25 of 140 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11331306 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Mohammed I. Dibas, Daniel W. Gil 2022-05-17
11208377 3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof Christopher D. Hein, Tien T. Duong, Santosh Sinha, Ling Li, Jeremiah H. Nguyen +4 more 2021-12-28
11046644 Sulfur derivatives as chemokine receptor modulators Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, Veena Viswanath, Michael E. Garst 2021-06-29
10993931 Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst 2021-05-04
10899780 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Richard L. Beard, Veena Viswanath 2021-01-26
10799518 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases Veena Viswanath, Richard L. Beard, Edward C. Hsia 2020-10-13
10555933 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Mohammed I. Dibas, Daniel W. Gil 2020-02-11
10434112 Use of agonists of formyl peptide receptor 2 for treating dermatological diseases Veena Viswanath, Richard L. Beard, Edward C. Hsia 2019-10-08
10287243 Sulfur derivatives as chemokine receptor modulators Haiqing Yuan, Richard L. Beard, Xiaoxia Liu, Veena Viswanath, Michael E. Garst 2019-05-14
10251865 Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists Daniel W. Gil, Veena Viswanath, Lauren M. Luhrs 2019-04-09
10208071 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Richard L. Beard, Veena Viswanath 2019-02-19
10201535 Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Mohammed I. Dibas, Edward C. Hsia, Daniel W. Gil 2019-02-12
10172832 Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst 2019-01-08
10123988 Compositions including encapsulated isotretinoin and methods for use thereof Rong Yang 2018-11-13
9974772 Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst 2018-05-22
9902710 Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Bertrand Leblond, Thierry Taverne, Cedric Chauvignac, Eric Beausoleil, Anne-Sophie Casagrande +3 more 2018-02-27
9889088 Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect Mohammed I. Dibas, Daniel W. Gil 2018-02-13
9868700 Carbamoyl hydrazine derivatives as formyl peptide modulators Vidyasagar Vuligonda, Thong Vu, Veena Viswanath, Richard L. Beard 2018-01-16
9850264 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Richard L. Beard, Veena Viswanath 2017-12-26
9849113 Methods of treating α adrenergic mediated conditions Daniel W. Gil, Wenkui K. Fang, Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh +3 more 2017-12-26
9828349 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Bertrand Leblond, Eric Beusoleil, Thierry Taverne 2017-11-28
9670181 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Bertrand Leblond, Cedric Chauvignac, Thierry Taverne, Eric Beausoleil, Anne-Sophie Casagrande +3 more 2017-06-06
9670190 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators Richard L. Beard, Veena Viswanath, Michael E. Garst, Haiqing Yuan, Xiaoxia Liu 2017-06-06
9670150 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators Richard L. Beard, Tien T. Duong, Veena Viswanath, Michael E. Garst 2017-06-06
9663460 Sulfur derivatives as chemokine receptor modulators Haiqing Yuan, Richard L. Beard, Michael E. Garst, Xiaoxia Liu, Veena Viswanath 2017-05-30